We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$4.71B
AUM Growth
+$53M
Cap. Flow
-$971M
Cap. Flow %
-20.64%
Top 10 Hldgs %
15.17%
Holding
850
New
129
Increased
145
Reduced
185
Closed
179

Sector Composition

Rank Sector Weight
1 Financials 25.53%
2 Technology 16.39%
3 Healthcare 9.58%
4 Industrials 6.86%
5 Consumer Discretionary 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLSIW icon
651
TriSalus Life Sciences Warrant
TLSIW
$26.6M
$3.79K ﹤0.01%
+61,658
New +$5.44K
MITAW
652
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$3.67K ﹤0.01%
33,333
GVCIW
653
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
$3.54K ﹤0.01%
35,374
COCHW icon
654
Envoy Medical Warrant
COCHW
$425K
$3.52K ﹤0.01%
93,480
OSI.WS
655
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$3.01K ﹤0.01%
25,000
NSTD.WS
656
DELISTED
Northern Star Investment Corp. IV Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTD.WS
$3K ﹤0.01%
83,333
BURU.WS
657
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$2.94K ﹤0.01%
57,441
TRTL.WS
658
DELISTED
TortoiseEcofin Acquisition Corp. III Warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TRTL.WS
$2.54K ﹤0.01%
25,325
ADERW
659
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$2.29K ﹤0.01%
82,786
BLUA.WS
660
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$1.88K ﹤0.01%
49,999
VIVE
661
DELISTED
VIVEVE MED INC
VIVE
$1.57K ﹤0.01%
+27,631
New +$17K
FOXO.WS
662
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$1.48K ﹤0.01%
46,050
FSRXW
663
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$1.33K ﹤0.01%
31,430
AMODW
664
Alpha Modus Holdings Warrant
AMODW
$330K
$667 ﹤0.01%
26,557
GLS.WS
665
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
$609 ﹤0.01%
243,446
GATE
666
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$3 ﹤0.01%
+300,000
New +$3.02M
CERO
667
DELISTED
CERo Therapeutics
CERO
$2 ﹤0.01%
+78
New +$1.64M
ZCAR
668
DELISTED
Zoomcar
ZCAR
$1 ﹤0.01%
+35
New +$733K
ACN icon
669
Accenture
ACN
$101B
-40,303
Closed -$10.8M
ADT icon
670
ADT
ADT
$5.62B
-661,428
Closed -$6M
AISP
671
Airship AI Holdings
AISP
$59.2M
-104,887
Closed -$1.06M
ALGN icon
672
Align Technology
ALGN
$12.1B
-4,040
Closed -$852K
ARKK icon
673
ARK Innovation ETF
ARKK
$5.61B
-24,353
Closed -$761K
AZN icon
674
AstraZeneca
AZN
$264B
-277,185
Closed -$37.6M
BNTX icon
675
BioNTech
BNTX
$23B
-3,074
Closed -$462K

Similar funds

Cantor Fitzgerald's Q1 2023 Portfolio in Review

As of Q1 2023, Cantor Fitzgerald held 850 positions worth $4.71B, up 1.1% from $4.65B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Cantor Fitzgerald withdrew a net $971M in Q1 2023, closing 179 positions and reducing 185 holdings. Its most notable exit was AstraZeneca, an estimated $37.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Cantor Fitzgerald opened a new position in Zimmer Biomet worth $19.8M.

  • Cantor Fitzgerald's largest Q1 2023 buy was Zimmer Biomet: 153,493 shares worth $19.8M.
  • Cantor Fitzgerald added most to Battery Future Acquisition Corp. in Q1 2023, an estimated $28.6M increase.
  • Cantor Fitzgerald's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $935M.
  • Cantor Fitzgerald fully exited AstraZeneca in Q1 2023, selling an estimated $37.6M.
  • Cantor Fitzgerald's ten largest holdings make up 15% of its $4.71B portfolio in Q1 2023.
  • Cantor Fitzgerald opened 129 new positions and closed 179 in Q1 2023.
  • Cantor Fitzgerald's portfolio value rose 1.1% quarter-over-quarter to $4.71B.

Based on Cantor Fitzgerald's 13F filing for Q1 2023, filed 15 May 2023.